FDA NDC Directory · JSON-LD · Markdown

Enjaymo

NDC 55292-820 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE

Generic namesutimlimab-jome
Labeler / ManufacturerRecordati Rare Diseases, Inc.
Marketing categoryBiologic License Application · App BLA761164
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE · INTRAVENOUS
Active ingredientsSUTIMLIMAB (50 mg/mL)
Marketing started20220204
Package count1

External sources

Source: openFDA. Public-domain (CC0).